we are way undervalued at this point entering 3 phase 3 trials in cli, and another for hip fracture,plus the ARS trial by the niaid, than you have p1 trial for bone marrow and blood cord if only 1 gets approved it gets us to $10.00. to me the risk of not being invested in psti when this thing gets going is a big missed opertunity and I'm not going to miss it.
News 
Market Data 
Discover 
